All Episodes
|
141
|
Robin Shah

Podcast 141: Oncology Super-Networks, Payers, And Their Impact On Patient Care with Robin Shah

Mar 25, 2022

Episode Summary

We took a long break — we've been busy at Darwin — but we’re back with a great lineup of guests for Season 6! We kick off this season with Robin Shah, Founder and CEO of Thyme Care and founding member of OneOncology. John and Robin discuss the classification of super-networks and break down the differences in existing models. Find out how payers are managing various disease states by outsourcing their risk and the impact it has on patient care. Please rate and review if you like Health Care Rounds as it helps other people find us!

Episode Notes

Robin Shah is the Founder and CEO of Thyme Care, an oncology care management solution providing high-touch, tech-enabled cancer care navigation. Thyme Care was founded with the mission to radically improve the journey for every person diagnosed with cancer.  At the heart of it all is the belief that providing patients with access to the right team at the right time will lead to better quality, outcomes, costs, and ultimately patient experience.

Before launching Thyme Care, Robin was a founding member of OneOncology, where he served as the Chief Development and Marketing Officer. Robin’s passion for building a stronger future for community oncology then brought him to Flatiron Health, a leading healthcare technology company. There, Robin served as Vice President of Provider Marketing and Strategy. Robin also helped manage a comprehensive community cancer center in his hometown, Gettysburg, PA.

Robin earned his bachelor’s degree in biomedical engineering from George Washington University and holds an M.B.A from the Carey Business School at Johns Hopkins University.

John Marchica, CEO, Darwin Research Group

John Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.

John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.

About Darwin Research Group

Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

‍

Recommended Next

Why Nobody is Winning The Payer-Provider AI Arms Race w/ Dr. Marc Harrison, TowerBrook Healthcare Institute
Mailbag: Virtual Nurses, Bundled Payments, and Single Payer
When MisInformation Becomes a Health Crisis w/ Dr. Joshua Sharfstein, Johns Hopkins
Real Health Care Happens Between Doctor Visits w/ Wei-Li Shao, President, Omada Health
Mailbag: Debunking Vaccines Myths
Health Care's Affordability Crisis Is Getting Worse w/ Larry Levitt, CEO-Elect & EVP, KFF
Are We Measuring Health Care Quality All Wrong? w/ Dr. Rachel Werner, Professor of Medicine, UPenn
The State of Value-Based Health Care w/ John Marchica, Darwin Research Group

Recommended Content

Browse Library
INsights
September 28, 2026

Telix to merge with ITM in deal worth up to $2.35 billion

Read More
INsights
September 21, 2026

FDA approves first treatment targeting muscle loss in spinal muscular atrophy

Read More
INsights
September 14, 2026

OpenAI announces integration of ChatGPT for Healthcare with Epic’s EHR

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.